South Korean biopharmaceutical company Celltrion announced on Monday that its self-diagnostic kit for Covid-19 has been granted emergency approval from US drug authorities. Celltrion DiaTrust Covid-19 Ag Home Test, co-developed by local healthcare business Humasis, received the US Food and Drug Administration’s emergency use authorisation approval, according to a company statement, Yonhap News Agency reported. The product uses an antibody that specifically binds to the Covid-19 virus and detects infection within 15 minutes, Celltrion said. It is most suitable for identifying acute or early infection of the Covid-19 virus. Celltrion USA, which handles Celltrion’s overseas business, will be responsible for the sales. The self-test kit has also been granted approval for emergency use by other countries, including South Korea. It is also used in several European countries,the report said.

Advertisements
Advertisements

Admin

SKY ELYSIAN l is the Chief Editor, and now writer for BLOCKONEDAILY. Being involved in the Bitcoin scene since 2015, he enjoys learning, and writing about new ways the blockchain technology can change...